Literature DB >> 2838911

Hematologic and hematopoietic consequences of B19 parvovirus infection.

N Young1.   

Abstract

In hybridization experiments, B19 shows some reactivity with autonomous rodent parvoviruses but none with adenoassociated virus sequences; its termini are more closely related to adenoassociated virus than to autonomous parvoviruses. B19 shares with all parvoviruses regions of conserved homology in the left side of the genome. The absence of an internal promoter and its unusual pattern of transcription sets B19 apart from both dependent and autonomous parvoviruses. Although clearly an autonomous parvovirus, in its extraordinary fastidious behavior B19 resembles a dependent parvovirus, capable of replication only in the special nuclear milieu of terminally differentiating erythroid cells. Adaptations at the molecular level may have been necessary for B19 parvovirus to acquire its high degree of specificity and low level of pathogenicity and thus succeed in human populations.

Entities:  

Mesh:

Year:  1988        PMID: 2838911

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  40 in total

1.  Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.

Authors:  S J Rosenfeld; K Yoshimoto; S Kajigaya; S Anderson; N S Young; A Field; P Warrener; G Bansal; M S Collett
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

2.  A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus.

Authors:  J M Liu; S W Green; T Shimada; N S Young
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

Review 3.  Parvovirus B19 infection in human pregnancy.

Authors:  R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2010-10-13       Impact factor: 6.531

4.  Concurrence of transient asplenia and pure red cell aplasia.

Authors:  M F Ozkaynak; J A Ortega; J Miller
Journal:  Eur J Pediatr       Date:  1990-05       Impact factor: 3.183

5.  A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response.

Authors:  K Yoshimoto; S Rosenfeld; N Frickhofen; D Kennedy; R Hills; S Kajigaya; N S Young
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

6.  Immune response to B19 parvovirus and an antibody defect in persistent viral infection.

Authors:  G J Kurtzman; B J Cohen; A M Field; R Oseas; R M Blaese; N S Young
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

7.  Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens.

Authors:  J P Clewley
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

Review 8.  Harmful and beneficial antibodies in immune thrombocytopenic purpura.

Authors:  P A Imbach
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

9.  A regional experience of red cell aplasia.

Authors:  J A Kynaston; N C West; M M Reid
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

10.  Parvovirus B19 infection, hepatitis C virus infection, and mixed cryoglobulinaemia.

Authors:  P Cacoub; N Boukli; P Hausfater; A Garbarg-Chenon; P Ghillani; V Thibault; L Musset; J M Huraux; J C Piette
Journal:  Ann Rheum Dis       Date:  1998-07       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.